Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy

Cao, HY; Li, L; Xue, SL; Dai, HP

Xue, SL; Dai, HP (通讯作者),Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou, Peoples R China.;Li, L (通讯作者),City Hope Med Ctr, Gehr Family Ctr Leukemia Res, Hematol Malignancies & Stem Cell Transplantat Ins, Beckman Res Inst,Dept Hematol Malignancies Transl, Duarte, CA 91010 USA.

HEMATOLOGICAL ONCOLOGY, 2023; 41 (3): 301

Abstract

Epigenetic alterations frequently participate in the onset of hematological malignancies. Histone deacetylases (HDACs) are essential for regulating ge......

Full Text Link